These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is azithromycin treatment associated with prolongation of the Q-Tc interval? Strle F; Maraspin V Wien Klin Wochenschr; 2002 Jun; 114(10-11):396-9. PubMed ID: 12708094 [TBL] [Abstract][Full Text] [Related]
3. Giant inverted T waves and substantial QT interval prolongation induced by azithromycin in an elderly woman with renal insufficiency. Yu T; Niu T Can Fam Physician; 2014 Nov; 60(11):1012-5. PubMed ID: 25392441 [No Abstract] [Full Text] [Related]
4. A case of QT-interval prolongation precipitated by azithromycin. Matsunaga N; Oki Y; Prigollini A N Z Med J; 2003 Nov; 116(1185):U666. PubMed ID: 14615808 [No Abstract] [Full Text] [Related]
5. Polymorphic ventricular tachycardia with a normal QT interval following azithromycin. Kim MH; Berkowitz C; Trohman RG Pacing Clin Electrophysiol; 2005 Nov; 28(11):1221-2. PubMed ID: 16359290 [No Abstract] [Full Text] [Related]
7. QT interval prolongation and extreme bradycardia after a single dose of azithromycin. Santos N; Oliveira M; Galrinho A; Oliveira JA; Ferreira L; Ferreira R Rev Port Cardiol; 2010 Jan; 29(1):139-42. PubMed ID: 20391905 [No Abstract] [Full Text] [Related]
8. Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia. Goldstein LH; Gabin A; Fawaz A; Freedberg NA; Schwartz N; Elias M; Saliba W Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1042-8. PubMed ID: 26238864 [TBL] [Abstract][Full Text] [Related]
9. A case-based approach to evaluating azithromycin use and cardiovascular risks. Wong E; Nguyen TV Consult Pharm; 2014 Jan; 29(1):47-52. PubMed ID: 24413014 [TBL] [Abstract][Full Text] [Related]
10. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677 [TBL] [Abstract][Full Text] [Related]
11. In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation. Lu HR; Vlaminckx E; Van de Water A; Rohrbacher J; Hermans A; Gallacher DJ Eur J Pharmacol; 2006 Dec; 553(1-3):229-39. PubMed ID: 17054943 [TBL] [Abstract][Full Text] [Related]
12. Azithromycin and the risk of cardiovascular complications. Maisch NM; Kochupurackal JG; Sin J J Pharm Pract; 2014 Oct; 27(5):496-500. PubMed ID: 25374989 [TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy. Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967 [TBL] [Abstract][Full Text] [Related]
16. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes? Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294 [TBL] [Abstract][Full Text] [Related]
17. Sibutramine-associated QT interval prolongation and cardiac arrest. Ernest D; Gershenzon A; Corallo CE; Nagappan R Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104 [TBL] [Abstract][Full Text] [Related]
19. Azithromycin/chloroquine combination does not increase cardiac instability despite an increase in monophasic action potential duration in the anesthetized guinea pig. Fossa AA; Wisialowski T; Duncan JN; Deng S; Dunne M Am J Trop Med Hyg; 2007 Nov; 77(5):929-38. PubMed ID: 17984356 [TBL] [Abstract][Full Text] [Related]
20. Arrhythmias associated with fluoroquinolone therapy. Falagas ME; Rafailidis PI; Rosmarakis ES Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]